Ozon Holdings PLC (OZON) Fundamental Analysis & Valuation

NASDAQ:OZON • US69269L1044

Current stock price

11.6 USD
-1.03 (-8.16%)
At close:
9.4 USD
-2.2 (-18.97%)
Pre-Market:

This OZON fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. OZON Profitability Analysis

1.1 Basic Checks

  • In the past year OZON has reported negative net income.
OZON Yearly Net Income VS EBIT VS OCF VS FCFOZON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 0 5B -5B -10B -15B -20B

1.2 Ratios

Industry RankSector Rank
ROA -21.98%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OZON Yearly ROA, ROE, ROICOZON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 -500 -1K -1.5K -2K

1.3 Margins

Industry RankSector Rank
OM -28.12%
PM (TTM) -30.33%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OZON Yearly Profit, Operating, Gross MarginsOZON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 0 -10 -20 -30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. OZON Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, OZON has more shares outstanding
  • Compared to 1 year ago, OZON has an improved debt to assets ratio.
OZON Yearly Shares OutstandingOZON Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 50M 100M 150M 200M
OZON Yearly Total Debt VS Total AssetsOZON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 50B 100B 150B

2.2 Solvency

  • Based on the Altman-Z score of 0.72, we must say that OZON is in the distress zone and has some risk of bankruptcy.
  • A Debt/Equity ratio of 1.61 is on the high side and indicates that OZON has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACCN/A
WACCN/A
OZON Yearly LT Debt VS Equity VS FCFOZON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 0 20B 40B 60B

2.3 Liquidity

  • OZON has a Current Ratio of 1.92. This is a normal value and indicates that OZON is financially healthy and should not expect problems in meeting its short term obligations.
  • OZON has a Quick Ratio of 1.67. This is a normal value and indicates that OZON is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.67
OZON Yearly Current Assets VS Current LiabilitesOZON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 20B 40B 60B 80B 100B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. OZON Growth Analysis

3.1 Past

  • OZON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -136.26%.
  • The Revenue has grown by 70.96% in the past year. This is a very strong growth!
  • OZON shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 67.44% yearly.
EPS 1Y (TTM)-136.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-217.21%
Revenue 1Y (TTM)70.96%
Revenue growth 3Y67.44%
Revenue growth 5YN/A
Sales Q2Q%84.93%

3.2 Future

  • OZON is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -21.70% yearly.
  • The Revenue is expected to grow by 62.13% on average over the next years. This is a very strong growth
EPS Next Y-182.2%
EPS Next 2Y-87.19%
EPS Next 3Y-46.97%
EPS Next 5Y-21.7%
Revenue Next Year74.83%
Revenue Next 2Y72.82%
Revenue Next 3Y64.59%
Revenue Next 5Y62.13%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
OZON Yearly Revenue VS EstimatesOZON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B 800B 1T
OZON Yearly EPS VS EstimatesOZON Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -100 -200 -300

More info and screens

Find the best growth stocksShow best growing peers

0

4. OZON Valuation Analysis

4.1 Price/Earnings Ratio

  • OZON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OZON. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OZON Price Earnings VS Forward Price EarningsOZON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -5.41
OZON Per share dataOZON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

  • A cheap valuation may be justified as OZON's earnings are expected to decrease with -46.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-87.19%
EPS Next 3Y-46.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OZON Dividend Analysis

5.1 Amount

  • No dividends for OZON!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

OZON Fundamentals: All Metrics, Ratios and Statistics

Ozon Holdings PLC

NASDAQ:OZON (2/25/2022, 8:02:43 PM)

Premarket: 9.4 -2.2 (-18.97%)

11.6

-1.03 (-8.16%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryInternet & Direct Marketing Retail
Earnings (Last)N/A
Earnings (Next)04-12
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.51B
Revenue(TTM)149.67B
Net Income(TTM)-45.39B
Analysts77
Price Target44.53 (283.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.38
P/FCF N/A
P/OCF N/A
P/B 4.29
P/tB N/A
EV/EBITDA -5.41
EPS(TTM)-2.74
EYN/A
EPS(NY)-4.04
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.38
BVpS2.71
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -21.98%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -28.12%
PM (TTM) -30.33%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.67
Altman-Z 0.72
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-217.21%
EPS Next Y-182.2%
EPS Next 2Y-87.19%
EPS Next 3Y-46.97%
EPS Next 5Y-21.7%
Revenue 1Y (TTM)70.96%
Revenue growth 3Y67.44%
Revenue growth 5YN/A
Sales Q2Q%84.93%
Revenue Next Year74.83%
Revenue Next 2Y72.82%
Revenue Next 3Y64.59%
Revenue Next 5Y62.13%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Ozon Holdings PLC / OZON Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for Ozon Holdings PLC?

ChartMill assigns a fundamental rating of 2 / 10 to OZON.


What is the valuation status of Ozon Holdings PLC (OZON) stock?

ChartMill assigns a valuation rating of 1 / 10 to Ozon Holdings PLC (OZON). This can be considered as Overvalued.


Can you provide the profitability details for Ozon Holdings PLC?

Ozon Holdings PLC (OZON) has a profitability rating of 1 / 10.


What is the expected EPS growth for Ozon Holdings PLC (OZON) stock?

The Earnings per Share (EPS) of Ozon Holdings PLC (OZON) is expected to decline by -182.2% in the next year.